Arcturus Therapeutics Holdings Inc.

The current price of ARCT is 27.64 USD — it has decreased by 8.26% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Arcturus Therapeutics Holdings Inc. stocks are traded under the ticker ARCT.

Arcturus Therapeutics Holdings Inc. is going to release the next earnings report on May 6, 2024. Keep track of upcoming events with our Earnings Calendar.

One year price forecast for Arcturus Therapeutics Holdings Inc. has a max estimate of 140.00 USD and a min estimate of 18.00 USD.

ARCT earnings for the last quarter are −0.61 USD whereas the estimation was −1.69 USD which accounts for 63.94% surprise. Estimated earnings for the next quarter are −0.99 USD. See more details about Arcturus Therapeutics Holdings Inc. earnings.

Yes, you can track Arcturus Therapeutics Holdings Inc. financials in yearly and quarterly reports right on TradingView.

Like other stocks, ARCT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Arcturus Therapeutics Holdings Inc. stock right from TradingView charts — choose your broker and connect to your account.

ARCT reached its all-time high on Oct 4, 2013 with the price of 188.72 USD, and its all-time low was 4.11 USD and was reached on Dec 28, 2018.
See other stocks reaching their highest and lowest prices.

As of Apr 18, 2024, the company has 180.00 employees. See our rating of the largest employees — is Arcturus Therapeutics Holdings Inc. on this list?

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Arcturus Therapeutics Holdings Inc. EBITDA is ‪−4.02 M‬ USD, and current EBITDA margin is −0.76%. See more stats in Arcturus Therapeutics Holdings Inc. financial statements.